Categories Technology

AT&T-Time Warner merger delivers rude reality check

One of AT&T’s (T) biggest promises during the battle for Time Warner was lower prices that the merger would bring about. However, a fortnight later, the reality is different. AT&T is hiking the price for many of its offerings, including its DirecTV Now streaming plans. The Justice Department had argued all along that price increases would be inevitable but that argument failed to prevail.

AT&T had promised that post the merger with Time Warner, prices would come down and it would have opportunities to offer more innovative products. Apart from DirecTV, AT&T has hiked prices for some of its other services and plans too and one of the reasons for this could be that the company is looking for fresh revenue streams post the costly merger which has increased its debt load.

Now that AT&T owns Time Warner, it does not have to negotiate with third parties for the content it provides. AT&T introduced a new unlimited wireless plan which includes its WatchTV streaming service. As the other providers are coming up with new channel bundles, the competition is likely to tighten not only on pricing but on the size and content of these bundles.

The Dallas-based conglomerate’s scale allows it to spread the costs wider among its large customer base that helps to improve profit margins and get better returns on invested capital. Although the AppNexus acquisition will bring in advertising revenues for AT&T, cord-cutting is likely to put pressure on the telecom giant’s pay-TV revenues. However, with its wireless capabilities, Time Warner programming and AppNexus advertising platform all rolling together, it looks like AT&T will not just prevail but see strength going forward.

Related: AT&T buys AppNexus, will compete with Facebook and Google in digital ad space

Related: Unconditional union: A peek into AT&T – Time Warner verdict

Related: Why the DoJ needs to appeal against the AT&T – Time Warner verdict

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top